Get the Stockscreener App
1.86
5.08%
0.09
After Hours:
1.88
0.02
+1.08%
Novabridge Biosciences Adr stock is traded at $1.86, with a volume of 713.25K.
It is up +5.08% in the last 24 hours and down -24.08% over the past month.
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
See More
Previous Close:
$1.77
Open:
$1.8
24h Volume:
713.25K
Relative Volume:
0.73
Market Cap:
$215.11M
Revenue:
$232.79M
Net Income/Loss:
$-88.69M
P/E Ratio:
-4.2091
EPS:
-0.4419
Net Cash Flow:
-
1W Performance:
+10.71%
1M Performance:
-24.08%
6M Performance:
-51.81%
1Y Performance:
+0.00%
1-Day Range:
$1.78
$1.945
1-Week Range:
$1.695
$1.945
52-Week Range:
$1.67
$5.19
Novabridge Biosciences Adr Stock (NBP) Company Profile
Name
Novabridge Biosciences Adr
Sector
Industry
Phone
-
Address
-
Compare NBP vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NBP
Novabridge Biosciences Adr
|
1.86 | 204.70M | 232.79M | -88.69M | 0 | -0.4419 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Novabridge Biosciences Adr Stock (NBP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-06-26 | Resumed | H.C. Wainwright | Buy |
| Oct-03-25 | Initiated | Leerink Partners | Outperform |
| Sep-09-25 | Initiated | BTIG Research | Buy |
| Dec-09-21 | Initiated | Siebert Williams Shank | Buy |
| Jun-02-21 | Initiated | Daiwa Securities | Buy |
| Mar-15-21 | Initiated | Needham | Buy |
| Mar-03-21 | Reiterated | H.C. Wainwright | Buy |
| Feb-25-21 | Initiated | Piper Sandler | Overweight |
| Dec-07-20 | Initiated | H.C. Wainwright | Buy |
| Jul-27-20 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-12-20 | Initiated | China Renaissance | Buy |
| Feb-11-20 | Initiated | Jefferies | Buy |
View All
Novabridge Biosciences Adr Stock (NBP) Latest News
TradingKey - TradingKey
Alpha Buying: Insider Conviction in High-Risk Biotech - Sahm
NovaBridge Biosciences president buys $577,300 in company shares By Investing.com - Investing.com India
NovaBridge Biosciences president buys $577,300 in company shares - Investing.com
NovaBridge appoints Mark Hagler as president, chief commercial officer - Investing.com
NovaBridge Biosciences (NASDAQ: NBP) posts 2025 loss, extends cash runway to 2028 - Stock Titan
H.C. Wainwright reiterates NovaBridge stock rating on FDA feedback - Investing.com India
NovaBridge gets FDA nod for accelerated approval path for givastomig - Investing.com
NovaBridge reports positive Phase 2a data for eye disease drug - Investing.com
NovaBridge to present Phase 2a data for wet AMD treatment VIS-101 - Investing.com India
NovaBridge enrolls first patient in phase 2 gastric cancer study By Investing.com - Investing.com India
NovaBridge enrolls first patient in phase 2 gastric cancer study - Investing.com
NovaBridge Biosciences stock price target raised to $9 by H.C. Wainwright - Investing.com Nigeria
NBP Stock Price and Chart — NASDAQ:NBP - TradingView
NovaBridge chairman to purchase up to $5 million in company shares By Investing.com - Investing.com Nigeria
NovaBridge chairman to purchase up to $5 million in company shares - Investing.com
Brookline Capital reiterates Buy rating on NovaBridge stock with $8 target By Investing.com - Investing.com South Africa
Brookline Capital reiterates Buy rating on NovaBridge stock with $8 target - Investing.com Nigeria
NovaBridge stock soars after positive gastric cancer drug results - Investing.com
NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026 - GlobeNewswire Inc.
Understanding RRC’s financial ratios: A beginner’s guide - uspostnews.com
NovaBridge Biosciences. ADR’s results are impressive - uspostnews.com
Faraday Future Intelligent Electric Inc (FFAI) looking to reclaim success with recent performance - setenews.com
NovaBridge to present extended dosing data for cancer drug ragistomig - Investing.com
Are Smart Investors Making the Right Decision? NovaBridge Biosciences. ADR (NBP) - Setenews
Evercore ISI resumes Aura Biosciences stock coverage with Outperform rating - Investing.com
What is the current Price Target and Forecast for NovaBridge Biosciences (NBP) - Zacks Investment Research
NovaBridge subsidiary Visara appoints two key ophthalmology leaders - Investing.com
Investors in cash trouble should check out NovaBridge Biosciences. ADR (NBP) - Setenews
Get in on Motorsport Games Inc’s (MSGM) buy-in window today! - Setenews
NovaBridge Biosciences Share Price ADS SPON - Hargreaves Lansdown
NovaBridge Biosciences (0VY.F) stock price, news, quote and history - Yahoo Finance Singapore
Prepare Yourself for Liftoff: Sandisk Corp (SNDK) - Setenews
NBP Financial Statements & ChartsNovabridge Biosciences.Adr MacroTrends - CMLviz
NBP Interactive Stock ChartNovabridge Biosciences.Adr. Stock Analysis - CMLviz
NBP Pivot Points, Technical Analysis and Moving AveragesNovabridge Biosciences.Adr Technicals - CMLviz
What date does NovaBridge Biosciences's (NBP) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
NBP Stock Price | Analyst Target 9.00 & Consensus - eToro
symbol__ Stock Quote Price and Forecast - CNN
NovaBridge Biosciences Sponsored ADR Earnings and Revenue – NASDAQ:NBP - TradingView — Track All Markets
NBP Forecast — Price Target — Prediction for 2026 - TradingView
NBPNovaBridge Biosciences. ADR Stock Price and Quote - Finviz
IMAB Stock Price, Quote & Chart | I-MAB-SPONSORED ADR (NASDAQ:IMAB) - ChartMill
I-Mab stock reaffirmed as Buy at H.C. Wainwright on positive cancer drug data - Investing.com
I-Mab Rebrands to NovaBridge Biosciences Following Shareholder Approval - TipRanks
I-Mab stock price target raised to $9 from $7 at BTIG on strategic shift - Investing.com
I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO - Investing.com
IMAB SEC FilingsI-Mab 10-K, 10-Q, 8-K Forms - Stock Titan
Invesco Nasdaq Biotechnology ETF Holdings - Quiver Quantitative
Most VolatileStock ScreenerNews - Finviz
Morningstar’s Best- and Worst-Performing Stocks: 2022 - Morningstar
Novabridge Biosciences Adr Stock (NBP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):